Literature DB >> 11292554

Clearance characteristics of chitosan based formulations in the sheep nasal cavity.

R J Soane1, M Hinchcliffe, S S Davis, L Illum.   

Abstract

This paper describes the clearance characteristics of two bioadhesive nasal delivery systems in the form of chitosan microspheres and chitosan solution, from the nasal cavity of conscious sheep. The pattern of deposition and clearance of the nasal dosage forms were evaluated using a radioactive tracer and the non-invasive technique of gamma scintigraphy. The clearance of chitosan microsphere and solution formulations was compared with that of a control solution. The data show that the control was cleared rapidly from the sheep nasal cavity with a half-time of clearance (time taken for 50% clearance; t(50%)) of about 15 min. The bioadhesive chitosan delivery systems were cleared at a slower rate, with half-times of clearance of 43 min and 115 min, for solution and microsphere formulations respectively. From the results reported in this study it can be concluded that the chitosan delivery systems investigated had significantly reduced rates of clearance from the sheep nasal cavity, as compared to the control. Consequently, chitosan delivery systems have the ability to increase the residence time of drug formulations in the nasal cavity thereby providing the potential for improved systemic medication. The nasal clearance rates recorded in the sheep model mimic very closely the clearance rates found in a previous study using human subjects. It can also be concluded that the sheep can be considered a suitable model for in vivo nasal clearance studies of novel bioadhesive drug delivery systems.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11292554     DOI: 10.1016/s0378-5173(01)00602-0

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  20 in total

1.  The effect of blood sampling site and physicochemical characteristics of drugs on bioavailability after nasal administration in the sheep model.

Authors:  L Illum; M Hinchcliffe; S S Davis
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

Review 2.  Absorption enhancers for nasal drug delivery.

Authors:  Stanley S Davis; Lisbeth Illum
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Pharmacokinetics and pharmacodynamics of nasally delivered midazolam.

Authors:  Manuel Haschke; Katja Suter; Sarah Hofmann; Robert Witschi; Johannes Fröhlich; Georgios Imanidis; Jürgen Drewe; Thomas A Briellmann; Franz E Dussy; Stephan Krähenbühl; Christian Surber
Journal:  Br J Clin Pharmacol       Date:  2010-06       Impact factor: 4.335

4.  Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1.

Authors:  William M Gwinn; Shaun M Kirwan; Sheena H Wang; Kathleen A Ashcraft; Neil L Sparks; Catherine R Doil; Tom G Tlusty; Leslie S Casey; Susan K Hollingshead; David E Briles; Richard S Dondero; Anthony J Hickey; W Michael Foster; Herman F Staats
Journal:  Vaccine       Date:  2010-08-17       Impact factor: 3.641

5.  Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics.

Authors:  Udhumansha Ubaidulla; Molugu V S Reddy; Kumaresan Ruckmani; Farhan J Ahmad; Roop K Khar
Journal:  AAPS PharmSciTech       Date:  2007-01-19       Impact factor: 3.246

6.  Surface characterisation of bioadhesive PLGA/chitosan microparticles produced by supercritical fluid technology.

Authors:  Luca Casettari; Enzo Castagnino; Snjezana Stolnik; Andrew Lewis; Steven M Howdle; Lisbeth Illum
Journal:  Pharm Res       Date:  2011-03-11       Impact factor: 4.200

7.  Evaluation of mucoadhesive PLGA microparticles for nasal immunization.

Authors:  Dilip Pawar; Amit K Goyal; Sharad Mangal; Neeraj Mishra; Bhuvaneshwar Vaidya; Shailja Tiwari; Arvind K Jain; Suresh P Vyas
Journal:  AAPS J       Date:  2010-01-15       Impact factor: 4.009

8.  Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles.

Authors:  A M Dyer; M Hinchcliffe; P Watts; J Castile; I Jabbal-Gill; R Nankervis; A Smith; L Illum
Journal:  Pharm Res       Date:  2002-07       Impact factor: 4.200

9.  A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies.

Authors:  Laura Nižić Nodilo; Ivo Ugrina; Drago Špoljarić; Daniela Amidžić Klarić; Cvijeta Jakobušić Brala; Mirna Perkušić; Ivan Pepić; Jasmina Lovrić; Vesna Saršon; Maša Safundžić Kučuk; Dijana Zadravec; Livije Kalogjera; Anita Hafner
Journal:  Pharmaceutics       Date:  2021-05-26       Impact factor: 6.321

10.  Agomelatine-based in situ gels for brain targeting via the nasal route: statistical optimization, in vitro, and in vivo evaluation.

Authors:  Ahmed M Fatouh; Ahmed H Elshafeey; Ahmed Abdelbary
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.